XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock Issued
Common Stock in Treasury
Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning balance at Dec. 31, 2023 $ 178,920 $ 253 $ (369,973) $ 336,938 $ (20,758) $ 232,460
Beginning balance (in shares) at Dec. 31, 2023     (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,649)         (8,649)
Currency translation adjustment (1,591)       (1,591)  
Shares issued for employee benefit plan and compensation (in shares)   156,000        
Shares issued for employee benefit plan and compensation 301 $ 2   299    
Purchase of treasury shares (in shares)     (140,000)      
Purchase of treasury shares (1,230)   $ (1,230)      
Shares issued to directors (in shares)   6,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,904     1,904    
Ending balance (in shares) at Mar. 31, 2024   25,508,000        
Ending balance at Mar. 31, 2024 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Ending balance (in shares) at Mar. 31, 2024     (12,600,000)      
Beginning balance (in shares) at Dec. 31, 2023   25,346,000        
Beginning balance at Dec. 31, 2023 178,920 $ 253 $ (369,973) 336,938 (20,758) 232,460
Beginning balance (in shares) at Dec. 31, 2023     (12,460,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (16,842)          
Currency translation adjustment $ (4,493)          
Purchase of treasury shares (in shares) (195,000)          
Purchase of treasury shares $ (1,841)          
Ending balance (in shares) at Jun. 30, 2024   25,627,000        
Ending balance at Jun. 30, 2024 159,771 $ 256 $ (371,814) 340,962 (25,251) 215,618
Ending balance (in shares) at Jun. 30, 2024     (12,655,000)      
Beginning balance (in shares) at Mar. 31, 2024   25,508,000        
Beginning balance at Mar. 31, 2024 169,655 $ 255 $ (371,203) 339,141 (22,349) 223,811
Beginning balance (in shares) at Mar. 31, 2024     (12,600,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (8,193)         (8,193)
Currency translation adjustment (2,902)       (2,902)  
Shares issued for employee benefit plan and compensation (in shares)   111,000        
Shares issued for employee benefit plan and compensation 362 $ 1   361    
Purchase of treasury shares (in shares)     (55,000)      
Purchase of treasury shares (611)   $ (611)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,460     1,460    
Ending balance (in shares) at Jun. 30, 2024   25,627,000        
Ending balance at Jun. 30, 2024 159,771 $ 256 $ (371,814) 340,962 (25,251) 215,618
Ending balance (in shares) at Jun. 30, 2024     (12,655,000)      
Beginning balance (in shares) at Dec. 31, 2024   25,713,000        
Beginning balance at Dec. 31, 2024 $ 153,105 $ 257 $ (371,930) 344,697 (28,350) 208,431
Beginning balance (in shares) at Dec. 31, 2024 (12,666,443)   (12,666,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (6,274)         (6,274)
Currency translation adjustment 1,578       1,578  
Shares issued for employee benefit plan and compensation (in shares)   124,000        
Shares issued for employee benefit plan and compensation 159 $ 1   158    
Purchase of treasury shares (in shares)     (41,000)      
Purchase of treasury shares (383)   $ (383)      
Shares issued to directors (in shares)   8,000        
Shares issued to directors 0          
Employee and director stock-based compensation 1,784     1,784    
Ending balance (in shares) at Mar. 31, 2025   25,845,000        
Ending balance at Mar. 31, 2025 149,969 $ 258 $ (372,313) 346,639 (26,772) 202,157
Ending balance (in shares) at Mar. 31, 2025     (12,707,000)      
Beginning balance (in shares) at Dec. 31, 2024   25,713,000        
Beginning balance at Dec. 31, 2024 $ 153,105 $ 257 $ (371,930) 344,697 (28,350) 208,431
Beginning balance (in shares) at Dec. 31, 2024 (12,666,443)   (12,666,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ (9,186)          
Currency translation adjustment $ 5,823          
Purchase of treasury shares (in shares) (101,000)          
Purchase of treasury shares $ (748)          
Ending balance (in shares) at Jun. 30, 2025   26,086,000        
Ending balance at Jun. 30, 2025 $ 152,759 $ 261 $ (372,678) 348,458 (22,527) 199,245
Ending balance (in shares) at Jun. 30, 2025 (12,767,292)   (12,767,000)      
Beginning balance (in shares) at Mar. 31, 2025   25,845,000        
Beginning balance at Mar. 31, 2025 $ 149,969 $ 258 $ (372,313) 346,639 (26,772) 202,157
Beginning balance (in shares) at Mar. 31, 2025     (12,707,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (2,912)         (2,912)
Currency translation adjustment 4,245       4,245  
Shares issued for employee benefit plan and compensation (in shares)   197,000        
Shares issued for employee benefit plan and compensation 172 $ 2   170    
Purchase of treasury shares (in shares)     (60,000)      
Purchase of treasury shares (365)   $ (365)      
Shares issued to directors (in shares)   44,000        
Shares issued to directors 1 $ 1        
Employee and director stock-based compensation 1,649     1,649    
Ending balance (in shares) at Jun. 30, 2025   26,086,000        
Ending balance at Jun. 30, 2025 $ 152,759 $ 261 $ (372,678) $ 348,458 $ (22,527) $ 199,245
Ending balance (in shares) at Jun. 30, 2025 (12,767,292)   (12,767,000)